AdaptHealth (NASDAQ:AHCO) Upgraded at Wall Street Zen

AdaptHealth (NASDAQ:AHCO) was upgraded by equities researchers at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a report issued on Saturday.

A number of other analysts have also recently commented on the stock. Zacks Research upgraded shares of AdaptHealth from a “strong sell” rating to a “hold” rating in a research note on Thursday, January 1st. Weiss Ratings cut shares of AdaptHealth from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday. Finally, Canaccord Genuity Group raised their target price on shares of AdaptHealth from $14.00 to $15.00 and gave the company a “buy” rating in a research note on Thursday, November 6th. Five research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $13.60.

AdaptHealth Stock Down 0.3%

AHCO stock opened at $10.61 on Friday. The company has a quick ratio of 0.86, a current ratio of 1.08 and a debt-to-equity ratio of 1.09. The business has a 50 day moving average price of $9.91 and a two-hundred day moving average price of $9.49. The company has a market cap of $1.44 billion, a price-to-earnings ratio of 19.29, a P/E/G ratio of 1.21 and a beta of 1.71. AdaptHealth has a twelve month low of $7.11 and a twelve month high of $11.63.

AdaptHealth (NASDAQ:AHCO) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $0.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.24 by ($0.05). The company had revenue of $820.31 million for the quarter, compared to the consensus estimate of $799.62 million. AdaptHealth had a return on equity of 4.85% and a net margin of 2.53%.The company’s revenue for the quarter was up 1.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.15 EPS. Analysts anticipate that AdaptHealth will post 0.88 EPS for the current fiscal year.

Insider Transactions at AdaptHealth

In other news, Director David Solomon Williams III sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, December 4th. The stock was sold at an average price of $9.43, for a total transaction of $47,150.00. Following the completion of the sale, the director owned 45,045 shares in the company, valued at $424,774.35. The trade was a 9.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 1.55% of the stock is owned by company insiders.

Institutional Trading of AdaptHealth

Hedge funds have recently added to or reduced their stakes in the company. Exchange Traded Concepts LLC bought a new stake in shares of AdaptHealth in the third quarter valued at about $1,171,000. GAMMA Investing LLC boosted its holdings in AdaptHealth by 38.7% in the 2nd quarter. GAMMA Investing LLC now owns 10,365 shares of the company’s stock valued at $98,000 after purchasing an additional 2,892 shares during the period. Allianz Asset Management GmbH raised its position in shares of AdaptHealth by 127.6% in the second quarter. Allianz Asset Management GmbH now owns 167,279 shares of the company’s stock valued at $1,577,000 after buying an additional 93,779 shares in the last quarter. Janney Montgomery Scott LLC boosted its stake in shares of AdaptHealth by 1.9% in the second quarter. Janney Montgomery Scott LLC now owns 80,301 shares of the company’s stock valued at $757,000 after buying an additional 1,511 shares during the period. Finally, Strs Ohio bought a new stake in shares of AdaptHealth in the first quarter valued at approximately $695,000. 82.67% of the stock is owned by institutional investors and hedge funds.

About AdaptHealth

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.